MARKET analysts at Datamonitor
have forecast that Novartis will
deliver the strongest prescription
drug sales growth of all Big
Pharma’s for the period 2009 - 2015.
The prediction, based on its
annual “organic performance”,
foresees that the company will have
an annual growth rate of 4% which
would result in around $10 billion
in sales.
Conversely, Datamonitor analysts
have forecast an average annual
growth rate for Big Pharma in
general of 1.4%.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.